Furthermore, the oncogenic version of KRAS protein, KRAS G12X, which is associated with aggressive disease in human cancer including malignant glioma [30–34], was shown to promote initiation and rapid tumour progression in a zebrafish model of human malignant glioma [35]. Here, KRAS is linked to malignant glioma.